AZR · Azora Therapeutics, Inc. (DE) · Debt
$4.00
+0.29 (+7.82%)
At close · Nov 6
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“the Company has concluded that there is substantial doubt about its ability to continue as a going concern.”View the 10-Q filed Aug 14, 2026
Market Cap
$10.50M
Shares
2.63M
Volume · Nov 6
78.19K
Avg daily vol (3M)
52.9K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Debt Profile
Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.
Read debt and covenant terms in your AI or your code through MCP and the API →Reported debt balances
Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.
| Reported balance | As of | Amount | Source |
|---|---|---|---|
| Current finance lease liabilities | 2023-03-31 | USD 58,751 | 10-Q filed 2023-05-12 |
| Noncurrent capital lease obligations | 2023-03-31 | USD 506,000 | 10-Q filed 2023-05-12 |
| Noncurrent operating lease liabilities | 2023-03-31 | USD 135,045 | 10-Q filed 2023-05-12 |
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.
Covenants
Covenant terms have not yet been verified for this profile.
The balance figures do not establish whether covenants apply or whether the company complies with them.
Loans, facilities and notes
The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.